0
Skip to Content
About
Team
Portfolio
Blog
News
California Innovation Fund
Work With Us
About
Team
Portfolio
Blog
News
California Innovation Fund
Work With Us
About
Team
Portfolio
Blog
News
Work With Us

Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes

Jan 6
Written by Lara Wilson
Lara Wilson
Previous
Previous

Vivere Oncotherapies Announces >$10M Funding to Develop Targeted Therapies for Solid Tumors

Next
Next

SixMap Launches New Product Capabilities to Improve Cyber Defense in the Face of AI-Driven Attacks

For general inquiries, please email info@calinnovationfund.com

Follow us on LinkedIn

 
 

About

Vision

Team

Work With Us

Entrepreneurs

Partners

Portfolio

 

©2022 California Innovation Fund LLC. All Rights Reserved.
Site Credits | Photography